A new trading day began on Monday, with Sagimet Biosciences Inc (NASDAQ: SGMT) stock price down -6.73% from the previous day of trading, before settling in for the closing price of $2.08. SGMT’s price has ranged from $2.03 to $7.38 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -20.00% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged -131.33%. With a float of $23.27 million, this company’s outstanding shares have now reached $30.67 million.
In an organization with 14 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Sagimet Biosciences Inc (SGMT) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Sagimet Biosciences Inc is 27.72%, while institutional ownership is 41.56%. The most recent insider transaction that took place on Jul 23 ’24, was worth 74,830. In this transaction Executive Chairman of this company sold 23,625 shares at a rate of $3.17, taking the stock ownership to the 118,693 shares. Before that another transaction happened on Jul 19 ’24, when Company’s Chief Medical Officer sold 8,357 for $3.10, making the entire transaction worth $25,910. This insider now owns 81,213 shares in total.
Sagimet Biosciences Inc (SGMT) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.88 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -131.33% per share during the next fiscal year.
Sagimet Biosciences Inc (NASDAQ: SGMT) Trading Performance Indicators
Here are Sagimet Biosciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 34.23.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.44, a number that is poised to hit -0.68 in the next quarter and is forecasted to reach -4.39 in one year’s time.
Technical Analysis of Sagimet Biosciences Inc (SGMT)
Let’s dig in a bit further. During the last 5-days, its volume was 1.11 million. That was better than the volume of 0.87 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 4.56%. Additionally, its Average True Range was 0.32.
During the past 100 days, Sagimet Biosciences Inc’s (SGMT) raw stochastic average was set at 3.72%, which indicates a significant decrease from 8.37% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 107.40% in the past 14 days, which was lower than the 115.89% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.85, while its 200-day Moving Average is $4.06. However, in the short run, Sagimet Biosciences Inc’s stock first resistance to watch stands at $2.03. Second resistance stands at $2.12. The third major resistance level sits at $2.27. If the price goes on to break the first support level at $1.79, it is likely to go to the next support level at $1.64. The third support level lies at $1.55 if the price breaches the second support level.
Sagimet Biosciences Inc (NASDAQ: SGMT) Key Stats
With a market capitalization of 59.51 million, the company has a total of 30,675K Shares Outstanding. Currently, annual sales are 0 K while annual income is -45,570 K. The company’s previous quarter sales were 0 K while its latest quarter income was -16,200 K.
